| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |